z-logo
open-access-imgOpen Access
Development and characterization of an animal model of carnitine deficiency
Author(s) -
Spaniol Markus,
Brooks Hilary,
Auer Lucas,
Zimmermann Arthur,
Solioz Marc,
Stieger Bruno,
Krähenbühl Stephan
Publication year - 2001
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1046/j.1432-1327.2001.02065.x
Subject(s) - carnitine , medicine , endocrinology , casein , chemistry , propionate , biosynthesis , biochemistry , enzyme , biology
Mammals cover their carnitine needs by diet and biosynthesis. The last step of carnitine biosynthesis is the conversion of butyrobetaine to carnitine by butyrobetaine hydroxylase. We investigated the effect of N ‐trimethyl‐hydrazine‐3‐propionate (THP), a butyrobetaine analogue, on butyrobetaine hydroxylase kinetics, and carnitine biosynthesis and body homeostasis in rats fed a casein‐based or a vegetarian diet. The K m of butyrobetaine hydroxylase purified from rat liver was 41 ± 9 µmol·L −1 for butyrobetaine and 37 ± 5 µmol·L −1 for THP, and THP was a competitive inhibitor of butyrobetaine hydroxylase ( K i 16 ± 2 µmol·L −1 ). In rats fed a vegetarian diet, renal excretion of total carnitine was increased by THP (20 mg·100 g −1 ·day −1 for three weeks), averaging 96 ± 36 and 5.3 ± 1.2 µmol·day −1 in THP‐treated and control rats, respectively. After three weeks of treatment, the total carnitine plasma concentration (8.8 ± 2.1 versus 52.8 ± 11.4 µmol·L −1 ) and tissue levels were decreased in THP‐treated rats (liver 0.19 ± 0.03 versus 0.59 ± 0.08 and muscle 0.24 ± 0.04 versus 1.07 ± 0.13 µmol·g −1 ). Carnitine biosynthesis was blocked in THP‐treated rats (−0.22 ± 0.13 versus 0.57 ± 0.21 µmol·100 g −1 ·day −1 ). Similar results were obtained in rats treated with the casein‐based diet. THP inhibited carnitine transport by rat renal brush‐border membrane vesicles competitively ( K i 41 ± 3 µmol·L −1 ). Palmitate metabolism in vivo was impaired in THP‐treated rats and the livers showed mixed steatosis. Steady‐state mRNA levels of the carnitine transporter rat OCTN2 were increased in THP‐treated rats in skeletal muscle and small intestine. In conclusion, THP inhibits butyrobetaine hydroxylase competitively, blocks carnitine biosynthesis in vivo and interacts competitively with renal carnitine reabsorption. THP‐treated rats develop systemic carnitine deficiency over three weeks and can therefore serve as an animal model for human carnitine deficiency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here